B

Bioventus Inc
NASDAQ:BVS

Watchlist Manager
Bioventus Inc
NASDAQ:BVS
Watchlist
Price: 11.71 USD 1.74% Market Closed
Market Cap: 950.3m USD
Have any thoughts about
Bioventus Inc?
Write Note

Wall Street
Price Targets

BVS Price Targets Summary
Bioventus Inc

Wall Street analysts forecast BVS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BVS is 14.96 USD with a low forecast of 12.12 USD and a high forecast of 17.85 USD.

Lowest
Price Target
12.12 USD
4% Upside
Average
Price Target
14.96 USD
28% Upside
Highest
Price Target
17.85 USD
52% Upside

BVS Last Price Targets
Bioventus Inc

The latest public price target was made on Oct 1, 2024 by Caitlin Cronin from Canaccord Genuity , who expects BVS stock to rise by 2% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Caitlin Cronin
Canaccord Genuity
12 USD
Upside 2%
1 month ago
Oct 1, 2024
Canaccord Genuity Reiterates Buy Rating on Bioventus Inc (BVS)
StreetInsider
Chase Knickerbocker
Craig-Hallum
12 USD
Upside 2%
3 months ago
Aug 7, 2024
Bioventus price target raised to $12 from $9 at Craig-Hallum
TheFly
William Plovanic
Canaccord Genuity
8 USD
Downside 32%
6 months ago
May 7, 2024
Bioventus Inc (BVS) PT Raised to $8 at Canaccord Genuity
StreetInsider
Alex Nowak
Craig-Hallum
9 USD
Downside 23%
8 months ago
Mar 13, 2024
Bioventus Inc (BVS) PT Raised to $9 at Craig-Hallum
StreetInsider
Caitlin Cronin
Canaccord Genuity
Price Target 12 USD
Upside/Downside 2%
View Source
Chase Knickerbocker
Craig-Hallum
Price Target 12 USD
Upside/Downside 2%
View Source
William Plovanic
Canaccord Genuity
Price Target 8 USD
Upside/Downside 32%
View Source
Alex Nowak
Craig-Hallum
Price Target 9 USD
Upside/Downside 23%
View Source
Bioventus Inc Competitors:
Price Targets
7730
Mani Inc
34% Upside
OMED
Jayamas Medica Industri TBK PT
62% Upside
MMSI
Merit Medical Systems Inc
7% Upside
688029
Micro-Tech Nanjing Co Ltd
31% Upside
300832
Shenzhen New Industries Biomedical Engineering Co Ltd
43% Upside
VIMIAN
Vimian Group AB
13% Upside
300595
Autek China Inc
24% Upside

Revenue
Forecast

Revenue Estimate
Bioventus Inc

For the last 8 years the compound annual growth rate for Bioventus Inc's revenue is 9%. The projected CAGR for the next 3 years is 7%.

9%
Past Growth
7%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Bioventus Inc

The compound annual growth rate of Bioventus Inc's operating income for the next 3 years is 333%.

N/A
Past Growth
333%
Estimated Growth
Estimates Accuracy
-74%
Average Miss

Net Income
Forecast

Net Income Estimate
Bioventus Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-67%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BVS's stock price target?
Price Target
14.96 USD

According to Wall Street analysts, the average 1-year price target for BVS is 14.96 USD with a low forecast of 12.12 USD and a high forecast of 17.85 USD.

What is Bioventus Inc's Revenue forecast?
Projected CAGR
7%

For the last 8 years the compound annual growth rate for Bioventus Inc's revenue is 9%. The projected CAGR for the next 3 years is 7%.

What is Bioventus Inc's Operating Income forecast?
Projected CAGR
333%

The compound annual growth rate of Bioventus Inc's operating income for the next 3 years is 333%.

Back to Top